FDA Drug Approval, N019422, EXIDINE

FDA Drug Approval, N019422, EXIDINE

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
NDA: 019422
Company: XTTRIUM
Drug Name: EXIDINE
Active Ingredients: CHLORHEXIDINE GLUCONATE
Strength: 2%
Dosage Form/Route: SOLUTION;TOPICAL
Action Date: 12/17/1985
Marketing Status: Over-the-counter
Submission Classification: Type 3 - New Dosage Form
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details